Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) Growth Rank: 6 (As of Jul. 26, 2026) — 200% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:ONCSM Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS IST:ONCSM
80 GF Score
Price ₺252.75
GF Value ₺256.02
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Oncosem Onkolojik Sistemlernayi ve Ticaret AS Growth Rank?

Oncosem Onkolojik Sistemlernayi ve Ticaret AS IST:ONCSM -3.71% 80 Growth Rank is 6 as of Jul. 26, 2026, which is 200% above its 10-year median of 2.00. GuruFocus rates IST:ONCSM with a GF Score™ of 80/100 and a GF Value™ of ₺256.02 (Fairly Valued). The stock has 4 warning signs investors should review.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS has the Growth Rank of 6.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Growth Rank Related Terms

IST:ONCSM vs ABT, SYK, MDT: Growth Rank Comparison

For the Medical Devices subindustry, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Growth Rank distribution charts can be found below:

* The bar in red indicates where Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Growth Rank falls into.


IST:ONCSM
80GF Score
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS IST:ONCSM
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 6 mean?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) has a Growth Rank of 6 as of Jul. 26, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Oncosem Onkolojik Sistemlernayi ve Ticaret AS and its competitors. This is 200% above median its historical median of 2.00. Over the past decade, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Growth Rank has ranged from 2.00 to 6.00.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Growth Rank too high?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current Growth Rank of 6 is 200% above median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 6.00. Overall, Oncosem Onkolojik Sistemlernayi ve Ticaret AS has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Growth Rank compare to ABT and SYK?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Growth Rank of 6 can be compared against companies in the Medical Devices & Instruments industry. Historically, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's own Growth Rank has ranged from 2.00 to 6.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Oncosem Onkolojik Sistemlernayi ve Ticaret AS and its competitors. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current Growth Rank is 6, which is 200% above median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) is currently considered Fairly Valued. The stock's GF Value™ is ₺256.02, compared to a current price of ₺252.75 — trading 1.3% below its estimated fair value. The current Growth Rank is 6, which is 200% above median its 10-year median of 2.00. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM), the current Growth Rank is 6 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) Overvalued in 2026?

Based on GuruFocus' analysis, Oncosem Onkolojik Sistemlernayi ve Ticaret AS stock appears to be undervalued. The current stock price of ₺252.75 is trading 1.3% below its estimated GF Value™ of ₺256.02. GuruFocus considers Oncosem Onkolojik Sistemlernayi ve Ticaret AS to be Fairly Valued.

Key valuation signals for IST:ONCSM:

  • Growth Rank: 6 (200% above median its 10-year median of 2.00)
  • GF Value™: ₺256.02 vs. price of ₺252.75 (1.3% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the IST:ONCSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Business Description

Address Mutlukent Mah. 1988 Cad. No: 12, Cankaya, Ankara, TUR
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is specialized in the production of equipment and medical devices used in cancer treatment.
80GF Score

Get the complete analysis for IST:ONCSM

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺252.75
Price
₺256.02
GF Value